期刊文献+

自身免疫甲状腺病患儿血清甲状腺刺激性抗体及甲状腺刺激阻断性抗体检测的意义 被引量:10

Significance of thyroid stimulating antibody and thyroid stimulating - blocking antibody in children with autoimmune thyroid disease
原文传递
导出
摘要 目的 探讨检测血清甲状腺刺激性抗体(TSAb)、甲状腺刺激阻断性抗体(TSBAb)对儿童Graves病(GD)、桥本甲状腺炎(HT)的意义。 方法 收集180例自身免疫甲状腺病(AITD)患儿的血清527份,分为GD组282份和HT组245份;甲状腺功能亢进(甲亢)组157份,缓解组279份,甲状腺功能减低(甲减)组91份;GD甲亢组127份和GD缓解组155份;HT甲亢组30份,HT缓解组124份,HT甲减组91份。选择79例同龄健康儿童作为健康对照组。分别用人血清TSAb和TSBAb ELISA试剂盒检测AITD患儿血清TSAb、TSBAb水平,采用化学发光法检测血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)水平,比较各组间TSAb、TSBAb的差异并分析TSAb、TSBAb与FT3、FT4、TSH的相关性。 结果 1.TSAb水平:GD组(0.727±0.157)〉HT组(0.605±0.148)〉健康对照组(0.350±0.105),差异有统计学意义(F=11.995,P=0.000);甲亢组(0.745±0.169)〉缓解组(0.647±0.153)〉甲减组(0.612±0.144)〉健康对照组(0.350±0.105),差异有统计学意义(F=122.770,P=0.000);GD甲亢组(0.747±0.170)〉GD缓解组(0.640±0.160)〉健康对照组(0.350±0.105),差异有统计学意义(F=156.712,P=0.000);HT甲亢组(0.739±0.140)〉HT缓解组(0.655±0.135)〉HT甲减组(0.612±0.140)〉健康对照组(0.350±0.105),差异有统计学意义(F=109.165,P=0.000)。2.TSBAb水平:HT组(0.704±0.633)〉GD组(0.567±0.178)〉健康对照组(0.334±0.104),差异有统计学意义(F=15.610,P=0.000);甲减组(0.693±0.125)〉缓解组(0.648±0.446)〉甲亢组(0.562±0.181)〉健康对照组(0.334±0.104),差异有统计学意义(F=13.311,P=0.000);GD缓解组(0.672±0.572)〉GD甲亢组(0.550±0.187)〉健康对照组(0.334±0.104),差异有统计学意义(F=19.269,P=0.000);HT甲减组(0.693±0.725)高于HT甲亢组(0.618±0.142)和HT缓解组(0.619±0.199),且均高于健康对照组(0.334±0.104);HT甲亢组(0.618±0.142)与HT缓解组(0.619±0.199)比较差异无统计学意义(F=12.208,P=0.00)。3.TSAb与TSBAb、FT3、FT4均呈正相关(r=0.162、0.091、0.194,P均〈0.05),与TSH呈负相关(r=-0.224,P〈0.05)。TSBAb与FT3呈负相关(r=-0.155,P〈0.05),与TSH呈正相关(r=0.131,P〈0.05)。 结论 AITD患儿甲状腺功能的变化与血清TSAb、TSBAb水平有关,TSAb、TSBAb对AITD患儿治疗过程中病情变化有预测作用。 Objective To study the significance of thyroid stimulating antibody (TSAb) and thyroid stimula- ting - blocking antibody (TSBAb) in children with Graves' disease ( GD ) or Hashimoto's thyroiditis (HT). Methods Five hundred and twenty - seven eases of serum from 180 children with autoimmune thyroid disease ( AITD ) children were divided into 282 cases of GD and 245 cases of HT. According to the status of thyroid function, they were divided into 157 cases of hyperthyroidism,91 cases of hypothyroidism and 279 cases of normal thyroid. GD group was subdivi- ded into 127 GD hyperthyroidism and 155 GD remission;HT group was subdivided 30 HT hyperthyroidism, 124 HT re- mission and 91 HT hypothyroidism. Seventy - nine healthy children were taken as the healthy control group. Free triiodothyronine (F'I3), free thyroxine( FF4 ) and sensitive thyroid stimulating hormone(TSH) were detected by chemo- Serum TSAb and TSBAb were detected by serum TSAb or TSBAb enzyme linked immunosorbent assay ( ELISA), respectively. The differences in TSAb and TSBAb among each group were compared and analyzed of find out the relationship between TSAb and TSBAb was performed. Beside, the correlation between TSAb and TSBAb with FT3, FT4, and TSH were analyzed. Results ( 1 ) TSAb levels were significant ( F = 11. 995, all P = 0. 000) : the GD group (0. 727 ± 0. 157 ) 〉 HT group (0. 605 ± 0. 148 ) 〉 healthy control group (0. 350± 0. 105 ) ; the difference was signifi- cant( F = 109. 165, P = 0. 000) among hyperthyroidism group (0. 745 ± 0. 169 ) 〉 normal thyroid group (0. 647 ± 0. 153 ) 〉 hypothyroidism group(0. 612 ± 0. 144) 〉 healthy control group (0.350 ± 0. 105 ) ;the difference was signifi- cant( F = 156. 712, P = 0. 000) in the GD hyperthyroidism group (0. 747± 0. 17 ) 〉 GD remission group ( 0. 640 ± 0. 16) 〉 healthy control group (0. 350 ±0. 105 ) ; the difference was significant (F = 109. 165, P = 0. 000) in the HThyperthyroidism group(0.739 ±0. 140) 〉 HT remission group(0. 655 ±0. 135 ) 〉 HT hypothyroidism group(0.612 ±0. 140) 〉healthy control group (0. 350 +0. 105). (2) TSBAb levels were significantly different (F = 15. 610,P = 0. 000) : the HT group (0.704 ±0.633 ) 〉 GD group (0.567 ± 0. 178 ) 〉 healthy control group ( 0. 334 ± 0. 104) ; the difference was significant(F = 13. 311, P = 0. 000) in the hypothyroidism group(0. 693± 0. 125 ) 〉 remission group (0. 648 ± 0.446) 〉 hyperthyroidism group (0. 562 ± 0.181 ) 〉 healthy control group (0. 334 ± 0. 104 ) ; the difference was significant(F = 19. 269,P =0. 000) in the GD remission group (0. 672 ±0. 572) 〉 GD hyperthyroidism group (0. 550 ±0. 187) 〉 healthy control group(0. 334 ±0. 104) ;HT hypothyroidism group(0. 693±0. 725) was higher than HT hyperthyroidism group(0.618 ±0. 142) and HT remission group (0.619 ±0. 199) ,the difference was not sig- nificant between HT hyperthyroidism group and HT remission group ( F = 12.208, P = 0.000). ( 3 ) TSAb level was posi- tively correlated with TSBAb, FI3 and FT4 ( r =- 0. 162,0. 091,0. 194, all P 〈 0.05 ) and was negatively correlated with TSH( r = - 0.224 ,P 〈 0.05 ). TSBAb levels were negatively correlated with FI3 ( r = - 0. 155, P 〈 0. 05 ) and was positively correlated with TSH( r = 0.131 ,P 〈 0.05 ). Conclusions Thyroid function was related to the serum levels of TSAb and TSBAb. TSAb and TSBAb could be regarded as an important predictive index for children with AITD during the treatment period.
作者 何娟 刘戈力
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2016年第8期600-603,共4页 Chinese Journal of Applied Clinical Pediatrics
关键词 Graves病 桥本甲状腺炎 促甲状腺激素受体刺激性抗体 促甲状腺激素受体刺激阻断性抗体 自身免疫甲状腺病 儿童 Graves' disease Hashimoto's thyroiditis Thyroid receptor stimulating antibody thyroid stimulating -blocking antibody Autoimmune thyroid disease Child
  • 相关文献

参考文献2

二级参考文献15

  • 1Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab, 1996,81:466-469.
  • 2Davies TF,Larsen PR. Thyrotixicosis//Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia : Saunders, 2002 : 423-456.
  • 3Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med, 2003,349:2646-2655.
  • 4Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort : Olmsted County, Minnesota, study. J Clin Endocrinol Metab, 2003, 88:2100-2105.
  • 5Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am, 1998,27 : 169-185.
  • 6滕卫平.甲状腺炎//叶任高.内科学.6版.北京:人民卫生出版社.2005:739-742.
  • 7高燕明,高妍.甲状腺炎//刘新民.实用内分泌学.3版.北京:人民军医出版社,2003:258-290.
  • 8白耀.甲状腺炎//白耀.甲状腺病学-基础与临床.北京:科学技术文献出版社,2004:305-323.
  • 9Schwarz-Lauer L, Chazenbalk GD, MclachIan SM, et al. Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid, 2002, 12:115-120.
  • 10Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves'disease. Trends Endocrinol Metab, 2005, 16 : 243-248.

共引文献606

同被引文献100

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部